<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:08:41" record="34900" source="Espacenet">
	<entities>
		<entity ref="Patent34900" type="Patent">
			<semanticIdentifier>brcris::ac46fbe8406880404b732ac9ed822841</semanticIdentifier>
			<semanticIdentifier>docdb::BRPI0504124A</semanticIdentifier>
			<semanticIdentifier>epodoc::BRPI0504124</semanticIdentifier>
			<semanticIdentifier>docdb::BRPI0504124A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR2005PI04124</semanticIdentifier>
			<semanticIdentifier>original::PIPI 0504124-4</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=PI0504124"/>
			<field name="identifier.lattes" value="0831378986076282"/>
			<field name="identifier.espacenet" value="PI0504124"/>
			<field name="kindCode" value="A"/>
			<field name="title.espacenet" value="processo para preparação de 7-cloro-1-[2-(dietilamino)etil]-5-(2-fluorofenil)-1,3-dihi dro-2h-1,4-benzodiazepin-2-ona"/>
			<field name="title.lattes" value="PROCESSO PARA PREPARAÇÃO DE 7-CLORO-1-[2-(DIETILAMINO)ETIL]-5-(2-FLUOROFENIL)-1,3-DIHIDRO-2H-1,4-BENZODIAZEPIN-2-ONA"/>
			<field name="depositDate" value="2005-03-01"/>
			<field name="publicationDate" value="2006-10-24"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ANDREA PEREIRA DOS SANTOS"/>
			<field name="inventor" value="BRUNO ALMEIDA COTRIM"/>
			<field name="inventor" value="JOSE HENRIQUE DE CARVALHO TERRA"/>
			<field name="inventor" value="MARCUS CESAR SOALHEIRO ALEXANDRINO DA CRUZ"/>
			<field name="inventor" value="OTAVIO VIANNA DE CARVALHO"/>
			<field name="inventor" value="ROGER HERMANN MEBUS"/>
			<field name="applicant" value="NORTEC QUIMICA S.A"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="C07D243/12AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="243"/>
				<field name="subgroup" value="12AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/4375AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="4375AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P25/20AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="25"/>
				<field name="subgroup" value="20AI"/>
			</field>
			<field name="abstract.espacenet" value="&quot;PROCESSO PARA PREPARAçãO DE 7-CLORO-1-¢2-(DIETILAMINO)ETIL!-5-(2-FLUOROFENIL)-1,3-DIHI DRO-2H-1,4-BENZODIAZEPIN-2-ONA&quot;. A preparação de flurazepam a partir da 5-(2-fluorofenil)-1,3-dihidro-7-cloro-2H-1,4-benzodiazepin-2-ona ocorre através da utilização de catalisador de transferência de fase, preferencialmente sais de amónio quaternários, em um sistema reacional bi-fásico, obtendo uma fase orgânica com o produto e subprodutos , os quais são adequadamente separados do solvente orgânico através da reação com excesso de ácido mineral aquoso, produzindo dicloridrato de flurazepam dissolvido na fase aquosa ácida. Esta fase aquosa ácida é alcalinizada com solução aquosa de uma base inorgânica até pH na faixa de 9 a 12 sendo então o produto flurazepam separado dos subprodutos por refrigeração da mistura reacional e isolado por filtração."/>
			<field name="originatesFrom" value="37137328"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="PI0504124"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BRPI0504124"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="PI0504124"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR2005PI04124"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value="PI"/>
				<field name="number" value="PI 0504124-4"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person24020" type="Person">
			<semanticIdentifier>lattes::0831378986076282</semanticIdentifier>
			<field name="identifier.lattes" value="0831378986076282"/>
			<field name="name" value="Otavio Vianna de Carvalho"/>
		</entity>
		<entity ref="OrgUnit18846" type="OrgUnit">
			<semanticIdentifier>brcris::20ee838f4dd65580254e1de95e320eb3</semanticIdentifier>
			<field name="name" value="NORTEC QUIMICA S.A"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent34900" toEntityRef="Person24020" type="Inventor"/>
		<relation fromEntityRef="Patent34900" toEntityRef="OrgUnit18846" type="Applicant"/>
	</relations>
</entity-relation-data>
